Gut microbe-derived metabolites and the risk of cardiovascular disease in the METSIM cohort

By sjmartinez • August 17, 2024

Mirzaei S, DeVon HA, Cantor RM, Cupido A, Fernandes Silva L, Laakso M, Lusis AJ. Gut microbe-derived metabolites and the risk of cardiovascular disease in the METSIM cohort. Front Microbiol. 2024 Aug 1;15:1411328. doi: 10.3389/fmicb.2024.1411328. PMID: 39149211; PMCID: PMC11324590.

Tags: Cardiology/Epi, cardiovascular disease, gut metabolites, myocardial infarction, Post Doc, Publications, stroke, succinate, ursodeoxycholic acid

Refractive Index-Corrected Light-Sheet Microscopy for Macro-View Cardiovascular Imaging

Zhu E, Zhang Y, Zhao P, Cho JM, Wang Z, Li YR, Wang J, Margolis S, Wang S, Yang L, Chu A, Zhang Y, Gao[...]

Bisphosphonate Use and Cardiovascular Outcomes According to Kidney Function Status in Post-Menopausal Women: An Emulated Target Trial from the Multi-Ethnic Study of Atherosclerosis

Ghotbi E, Subhas N, Bancks MP, Elmariah S, Halperin JL, Bluemke DA, Kestenbaum BR, Barr RG, Post WS, Budoff M, Lima JAC, Demehri S. Bisphosphonate[...]

Acute Cardiogenic Shock Secondary to Left Main Occlusion in a Patient with Behçet Disease

Sekhon HK, Sareh S, Kellner D, Yiu G, Benharash P, Hollowed J, Shahandeh N. Acute Cardiogenic Shock Secondary to Left Main Occlusion in a Patient[...]